Hepatitis C Treatment MarketPosted by ahila on April 24th, 2018 Hepatitis C treatment market: Hepatitis C is an infectious disease caused by Hepatitis C virus (HCV) and affects primarily the liver. Hepatitis C is commonly caused by blood to blood contacts such as intravenous drug use, unsterilized equipment, blood transfusions, and sexual intercourse. Hepatitis C may also cause from mother to fetus during birth. People with alcoholism and HIV infection of any age group are at increased risk. Currently, there is no vaccine available to treat hepatitis C conditions. However, various drugs such as protease inhibitors, HCV polymerase inhibitors, and HCV NS5A inhibitors are commonly used to treat Hepatitis C. Early stage of infection typically has no symptoms. The critical stage of infection may display symptoms such as fever, dark urine, abdominal pain, and yellow-tinged skin occurrence. The severity in hepatitis C may lead to liver cirrhosis, liver cancer, liver failure, and sometimes also causes the dilated blood vessels in the oesophagus and stomach. Hepatitis C can be prevented by using sterilized equipment, screening of blood donors, avoiding multiple sexual partners, and avoiding sharing of injections and razors. Global Market Outline: Hepatitis C Treatment Market The global market for Hepatitis C treatment market is expected to grow at a significant CAGR due to increase in the prevalence of Hepatitis C infection. Rising awareness regarding Hepatitis C treatment, increase in healthcare expenditure, and government initiatives and various NGO’s creating awareness regarding the Hepatitis C treatment is expected to fuel the market growth over the forecast period. In addition, rise in the funding in research and development activities for Hepatitis C treatment and strong pipeline products might boost the global Hepatitis C treatment market over the forecast period. However, lack of antibiotics in the market, high cost of medications, and lack of hepatitis C infection awareness in poor countries might hamper the growth of global Hepatitis C treatment market over the forecast period. A sample of this report is available upon request @ Hepatitis C treatment market segmented on the basis of drug class, route of administration, and distribution channel Based on drug class, the hepatitis C treatment market has been segmented into the following:
Based on route of administration, the hepatitis C treatment market has been segmented into the following:
Based on distribution channel, the hepatitis C treatment market has been segmented into the following:
To view TOC of this report is available upon request @ Like it? Share it! More by this author |